These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34033286)

  • 1. Body composition, but not insulin resistance, influences postprandial lipemia in patients with Turner's syndrome.
    de Azeredo Siqueira R; Carlos AS; d'Avila JC; Moreno AM; Alves EL; de Farias MLF; Mendonça LMC; Guimarães MM
    Arch Endocrinol Metab; 2021 May; 64(6):758-763. PubMed ID: 34033286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement.
    Gravholt CH; Naeraa RW; Nyholm B; Gerdes LU; Christiansen E; Schmitz O; Christiansen JS
    Diabetes Care; 1998 Jul; 21(7):1062-70. PubMed ID: 9653596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome.
    Salgin B; Amin R; Yuen K; Williams RM; Murgatroyd P; Dunger DB
    Horm Res; 2006; 65(2):69-75. PubMed ID: 16407654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone.
    Gravholt CH; Christian Klausen I; Weeke J; Sandahl Christiansen J
    Atherosclerosis; 2000 May; 150(1):201-8. PubMed ID: 10781652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and cardiovascular outcomes in a group of adult patients with Turner's syndrome under hormonal replacement therapy.
    Giordano R; Forno D; Lanfranco F; Manieri C; Ghizzoni L; Ghigo E
    Eur J Endocrinol; 2011 May; 164(5):819-26. PubMed ID: 21378088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and body composition in Turner syndrome: Effect of sequential change in the route of estrogen administration.
    Alves ST; Gallichio CT; Guimarães MM
    Gynecol Endocrinol; 2006 Oct; 22(10):590-4. PubMed ID: 17135039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of transdermal and oral estrogen therapy in girls with Turner's syndrome.
    Jospe N; Orlowski CC; Furlanetto RW
    J Pediatr Endocrinol Metab; 1995; 8(2):111-6. PubMed ID: 7584704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome.
    Elsheikh M; Bird R; Casadei B; Conway GS; Wass JA
    J Clin Endocrinol Metab; 2000 Feb; 85(2):614-8. PubMed ID: 10690864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.
    O'Sullivan AJ; Crampton LJ; Freund J; Ho KK
    J Clin Invest; 1998 Sep; 102(5):1035-40. PubMed ID: 9727072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance: an early metabolic defect of Turner's syndrome.
    Caprio S; Boulware S; Diamond M; Sherwin RS; Carpenter TO; Rubin K; Amiel S; Press M; Tamborlane WV
    J Clin Endocrinol Metab; 1991 Apr; 72(4):832-6. PubMed ID: 2005209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome.
    Mauras N; Shulman D; Hsiang HY; Balagopal P; Welch S
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4154-60. PubMed ID: 17711924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exaggerated effects of progestogen on uterine artery pulsatility index in Turner's syndrome patients receiving hormone replacement therapy.
    Biljan MM; Taylor CT; Matijevic R; Jones SV; Garden AS; Fraser WD; Diver MJ; Kingsland CR
    Fertil Steril; 1995 Dec; 64(6):1104-8. PubMed ID: 7589660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone.
    Bertelloni S; Cinquanta L; Baroncelli GI; Simi P; Rossi S; Saggese G
    Horm Res; 2000; 53(2):72-6. PubMed ID: 10971092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.
    Umpaichitra V; Banerji MA; Castells S
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):853-64. PubMed ID: 15270403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation between serum adipokines levels and metabolic indicators in girls with Turner syndrome.
    Zhang Y; Chen RM; Lin XQ; Yuan X; Yang XH
    Cytokine; 2019 Jan; 113():139-143. PubMed ID: 29983357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity.
    Reiter JC; Craen M; Van Vliet G
    Acta Endocrinol (Copenh); 1991 Jul; 125(1):38-42. PubMed ID: 1872123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of oral versus transdermal 17β-estradiol (E₂): a randomized clinical trial in girls with Turner syndrome.
    Torres-Santiago L; Mericq V; Taboada M; Unanue N; Klein KO; Singh R; Hossain J; Santen RJ; Ross JL; Mauras N
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2716-24. PubMed ID: 23678038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting triglyceride is a major determinant of postprandial triglyceride response in postmenopausal women.
    Hwu CM; Lin MW; Liou TL; Hsiao LC; Liang KW; Tsai TT; Ho LT
    Menopause; 2008; 15(1):150-6. PubMed ID: 17549035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
    Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
    Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.